Most recently, it's been identified that conolidine and the above mentioned derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in very similar places as classical opioid receptors, it binds to the big selection of endogenous opioids. Compared with most opioid receptors, this receptor functions for a scavenger and isn't going